InFlectis BioScience

Nantes, France

InFlectis BioScience is a private drug discovery company aiming at targeting.

$650K raised

Apr 2024

Grant

Biopharma Biotechnology Health Care Medical Pharmaceutical

Top Investors

GO CAPITAL Remiges Ventures The ALS Association National Multiple Sclerosis Society (NMSS)Crédit Mutuel Innovation

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about InFlectis BioScience

How much funding has InFlectis BioScience raised?

InFlectis BioScience has raised $650K in total funding. The most recent round was Grant. The last funding was announced in April 2024.

Who are InFlectis BioScience's investors?

InFlectis BioScience's investors include GO CAPITAL, Remiges Ventures, The ALS Association, National Multiple Sclerosis Society (NMSS), Crédit Mutuel Innovation.

Where is InFlectis BioScience headquartered?

InFlectis BioScience is headquartered in Nantes, France.

What does InFlectis BioScience do?

InFlectis BioScience is a private drug discovery company aiming at targeting.

What stage is InFlectis BioScience at?

InFlectis BioScience is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 30, 2024.

MLA

"InFlectis BioScience — Funding & Investors." VCBacked, April 30, 2024, https://www.vcbacked.co/company/inflectis-bioscience. Accessed July 2, 2026.

APA

VCBacked. (2024). InFlectis BioScience — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/inflectis-bioscience

Wikipedia (cite web)

{{cite web |title=InFlectis BioScience — Funding & Investors |url=https://www.vcbacked.co/company/inflectis-bioscience |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 30, 2024.